1. Stocks
  2. Protara Therapeutics Inc
  3. Swot
swot-logo

Protara Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Protara Therapeutics Inc has 10 Strengths, 10 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding

Stocks with Quarter Change % less than Industry

Negative profit growth, promoters decreasing shareholding QoQ

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Institutions decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks